Globela Pharma Profile
Key Indicators
- Authorised Capital ₹ 58.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 56.92 Cr
as on 16-11-2024
- Company Age 18 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 168.62 Cr
as on 16-11-2024
- Satisfied Charges ₹ 16.00 Cr
as on 16-11-2024
- Revenue 11.14%
(FY 2023)
- Profit 22.79%
(FY 2023)
- Ebitda 4.71%
(FY 2023)
- Net Worth 33.16%
(FY 2023)
- Total Assets 24.40%
(FY 2023)
About Globela Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 58.00 Cr and a paid-up capital of Rs 56.92 Cr.
The company currently has active open charges totaling ₹168.62 Cr. The company has closed loans amounting to ₹16.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Globela Pharma Private Limited India is Tony Gandhi as COMPANY SECRETARY. Bhanubhai Vaghashia, Mayur Sirdesai, Pietro Stefanutti, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230GJ2006PTC047699
- Company No.
047699
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Feb 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Globela Pharma Private Limited offer?
Globela Pharma Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Anti Infective Agent, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Digestive System Drugs & Medicines, Antispasmodic Drugs, Antibiotic Tablets, Capsule & Syrup, Pharma Ingredients & Raw Materials, Anti Infective API, Laxatives.
Who are the key members and board of directors at Globela Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhanubhai Vaghashia  | Managing Director | 08-Feb-2006 | Current |
| Tony Gandhi | Company Secretary | 21-May-2021 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Priyank Vaghashia | Director | 23-Sep-2021 | Current |
| Mayur Sirdesai | Director | 23-Sep-2021 | Current |
Pietro Stefanutti  | Director | 13-Jan-2022 | Current |
| Urmilaben Vaghasiya | Director | 25-Oct-2010 | Current |
Financial Performance and Corporate Structure Insights of Globela Pharma.
Globela Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.14% increase. The company also saw a substantial improvement in profitability, with a 22.79% increase in profit. The company's net worth Soared by an impressive increase of 33.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Globela Pharma?
In 2023, Globela Pharma had a promoter holding of 74.21% and a public holding of 25.79%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Globela Industries Private LimitedActive 4 years 2 monthsBhanubhai Vaghashia, Tony Gandhi and 1 more are mutual person
Somerset Health Capital Advisors Private LimitedActive 13 years 9 monthsMayur Sirdesai is a mutual person
- Somerset Healthcare Investment Advisors Private LimitedActive 10 years 3 months
Mayur Sirdesai is a mutual person
Globela Laboratories Private LimitedActive 2 years 9 monthsBhanubhai Vaghashia and Priyank Vaghashia are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 05 Aug 2024 | ₹7.35 Cr | Open |
Axis Bank Limited Creation Date: 06 May 2022 | ₹22.06 Cr | Open |
Axis Bank Limited Creation Date: 25 Mar 2022 | ₹54.47 Cr | Open |
How Many Employees Work at Globela Pharma?
Globela Pharma has a workforce of 144 employees as of Jul 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Globela Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Globela Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
